Could Stroke Trials Be Missing Important Treatment Effects?

Publisher： Karger

E-ISSN： 1421-9786|13|1|73-75

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.13, Iss.1, 2002-01, pp. : 73-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Estimating the Number of Stroke Patients Eligible for Thrombolytic Treatment if Delay Could Be Avoided

By  

Cerebrovascular Diseases, Vol. 23, Iss. 4, 2006-12 ,pp. : 294-298

Karger

Access to resources Recommend Favorite

Endovascular Treatment for Acute Ischemic Stroke: Considerations from Recent Randomized Trials

By  

Interventional Neurology, Vol. 3, Iss. 3-4, 2015-03 ,pp. : 115-121

Karger

Access to resources Recommend Favorite

The Scribe of Stroke Trials

By  

European Neurology, Vol. 49, Iss. 2, 2003-02 ,pp. : 125-127

Karger

Access to resources Recommend Favorite

Halving Effort in Acute Stroke Trials

By Lees Kennedy   Milia Paolo  

Clinical and Experimental Hypertension, Vol. 28, Iss. 3-4, 2006-07 ,pp. : 309-312

Informa Healthcare

Access to resources Recommend Favorite

Randomized Clinical Stroke Trials in 2006

By  

Current Vascular Pharmacology, Vol. 6, Iss. 1, 2008-01 ,pp. : 61-66

Bentham Science Publishers

Access to resources Recommend Favorite